Aurinia Pharmaceuticals AUPH Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's work in process?
- Aurinia Pharmaceuticals (AUPH) reported work in process of $41.42M in Q1 2026.
- How has Aurinia Pharmaceuticals's work in process changed year-over-year?
- Aurinia Pharmaceuticals's work in process decreased by 0.8% year-over-year, from $41.75M to $41.42M.
- What is the long-term trend for Aurinia Pharmaceuticals's work in process?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's work in process has grown at a 26.2% compound annual growth rate (CAGR), from $13.93M to $44.65M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.